# Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)

> **NCT04434300** · PHASE1 · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 12 (actual)

## Conditions studied

- Antibiotics
- Subcutaneous Injection
- Daptomycin

## Interventions

- **DRUG:** Daptomycin
- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT04434300
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2021-01-15
- **Final completion:** 2021-11-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434300, "Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04434300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*